会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 7. 发明授权
    • Anthracyclines and drugs containing them
    • 蒽环类药物和含有它们的药物
    • US4789665A
    • 1988-12-06
    • US941604
    • 1986-12-15
    • Jean-Pierre GessonMartine MondonJean-Claude JacquesyHans P. Kraemer
    • Jean-Pierre GessonMartine MondonJean-Claude JacquesyHans P. Kraemer
    • A61K31/70A61K31/7028A61K31/7034A61K31/704A61P35/00C07H15/252C07H15/24
    • C07H15/252
    • The present invention relates to new anthracyclines corresponding to the general formula I below: ##STR1## in which R' and R", which may be identical or different, denote a hydrogen atom (and in this case R' is different from R") or the group --(CH.sub.2).sub.n --R.sub.1 --(CH.sub.2).sub.m --R.sub.2 where n is between 1 and 6,m is between 0 and 4 (with the proviso, of course, that if m=0, R.sub.2 is nonexistent)R.sub.1 denotes one of the following groups: ##STR2## (in this case, m=0) ##STR3## (in this case m=0) where R.sub.3 and R.sub.4, which may be identical or different, denote a hydrogen atom or a substituted or unsubstituted alkyl group)--C.tbd.N (in this case m=0)--S----O--(with the proviso that m is other than 0) ##STR4## (m=0 and R.sub.3 R.sub.4 have the same meaning as above) and R.sub.2 denotes (in the case where m is other than 0) a hydrogen atom or alkyl or alkoxy groups or ##STR5## (R.sub.3 and R.sub.4 having the same meaning as above). These compounds possess cytotoxic properties for treating L1210 leukemia.
    • 本发明涉及对应于以下通式I的新型蒽环类抗生素:其中R'和R“可以相同或不同,表示氢原子(在这种情况下,R'不同 (CH 2)n -R 1 - (CH 2)m -R 2,其中n为1至6,m为0至4(条件是当m = 0时, R2不存在)R1表示以下组之一:(在这种情况下,m = 0)(在这种情况下为m = 0)其中R3和R4可以相同或不同,表示氢 原子或取代或未取代的烷基)-C 3 N(在这种情况下,m = 0)-S- -O-(条件是m不为0)(m = 0且R 3 R 4具有 与上述相同),R2表示(在m不为0的情况下)氢原子或烷基或烷氧基或具有与上述相同含义的R3和R4。 这些化合物具有治疗L1210白血病的细胞毒性。